Host-Cell Proteins: Implications for Protein-Drug Efficacy - BioProcess InternationalBioProcess International

Host cell protein content is often identified as a critical quality attribute and is often used as a benchmark during biologics manufacturing.

Exploring sample preparation and data evaluation strategies for enhanced identification of host cell proteins in drug products of therapeutic antibodies and Fc-fusion proteins

Host cell receptor/molecules/factors as therapeutic targets for

Posttranslational Modifications and Their Control in CHO Culture - BioProcess InternationalBioProcess International

Host-Cell Proteins: Implications for Protein-Drug Efficacy - BioProcess InternationalBioProcess International

HCP Enrichment During CGMP Scale-Up - BioProcess InternationalBioProcess International

HCP Assay Development: Managing Risks - BioProcess InternationalBioProcess International

Downstream Processing Archives - Page 4 of 46 - BioProcess InternationalBioProcess International

Daily Exposure for Inactivated Therapeutic Proteins - BioProcess InternationalBioProcess International

PDF] Host Cell Protein Analysis in Biologic Drug Development

Science, Risks, and Regulations: Current Perspectives on Host Cell Protein Analysis and Control - BioProcess InternationalBioProcess International

Host-Cell Protein Risk Management and Control During Bioprocess Development: A Consolidated Biotech Industry Review, Part 1 - BioProcess InternationalBioProcess International